simulation of dissolution

Noyes–Whitney Drug Dissolution Simulator

Noyes–Whitney Dissolution Engine

Biopharmaceutics & Drug Release Kinetics

Governing Transport ODE Sink Conditions Active (< 15% Cs)
$$\frac{dC}{dt} = \frac{D \cdot A(t)}{h \cdot V} \cdot (C_s - C(t))$$
Formulation Presets:
D: Diffusion Coeff

Solute mobility across boundary layer

A(t): Surface Area

Solute-solvent interfacial contact

h: Stagnant Layer

Diffusion thickness (modulated by stirring)

Cs: Saturation Sol.

Thermodynamic equilibrium solubility

C(t): Bulk Conc.

Instantaneous dissolved concentration

Cs - C: Driving Force

Chemical potential gradient driving dissolution

Physical Parameters

SI & Bio units
20.0 µg/mL
Poorly Soluble (2 µg/mL) Moderate (100 µg/mL)
5.0 µm
Sub-micron (0.5 µm) Coarse Granule (80 µm)
25.0 µm
Turbulent / High RPM (5 µm) Gentle / Static (60 µm)
5.5 cm²/s

Typical small molecule aqueous diffusivity is 4–8 × 10⁻⁶ cm²/s

mg
mL
60 min

Particle & Stagnant Layer ($h$)

r(t): 5.0 µm
Inner: Solid API • Outer ring: Diffusion Layer $h$
Drug concentration declines smoothly from $C_s$ at the particle interface across stagnant boundary thickness $h$ into bulk solution $C(t)$.
Dissolution at Horizon 0.0% 0.00 mg dissolved
Initial Rate ($dC/dt_0$) 0.00 µg / (mL · min)
Time to 80% ($T_{80}$) -- Pharmacopeial threshold
Specific Surface Area 0.00 m² / g API

Drug Concentration Profile $C(t)$

Shrinking Particle (Spherical ODE) vs. Idealized Constant Surface Area

Shrinking Particle (Realistic) Constant Area

Particle Radius $r(t)$ & Area Decay

Micrometers (µm)

Instantaneous Rate $dC/dt(t)$

µg / (mL · min)

Theoretical Foundations & Biopharmaceutics Formulation Levers

How physicochemical parameters dictate in vitro dissolution testing and oral bioavailability (BCS Class II drugs).

1. Surface Area ($A$) & Micronization

The dissolution rate is directly proportional to total interfacial contact area $A$. For spherical particles of radius $r_0$ and density $\rho$, specific surface area scales as: SSA = 3 / (ρ · r₀) Reducing particle radius by a factor of 10 increases the available surface area tenfold for the same mass dose, dramatically accelerating the initial dissolution velocity. This is the biopharmaceutical rationale for micronization, wet bead milling, and nanosuspensions.

2. Hydrodynamics & Boundary Layer ($h$)

Surrounding every dissolving particle is a microscopic stagnant fluid film across which solute molecules must diffuse purely by Brownian motion. According to Levich hydrodynamic theory, agitation speed ($\omega$) compresses this layer: h ∝ ω^(-1/2) Higher gastrointestinal motility or dissolution paddle speeds (e.g. 50 vs. 100 RPM in USP Apparatus II) thin this barrier, elevating $dC/dt$.

3. Driving Force $(C_s - C)$ & Sink Conditions

Dissolution rate is driven by chemical chemical disequilibrium. As solute accumulates in the bulk volume, $C(t) \to C_s$, reducing driving force $(C_s - C)$ towards zero. In biopharmaceutics, sink conditions are defined when $C(t) < 0.1 \sim 0.2 \, C_s$, preserving maximal driving force. Strategies like surfactant micellization, salt formation, or amorphous solid dispersions (ASDs) generate temporary "spring and parachute" supersaturation by elevating $C_s$.

Coupled ODE Formulation: Shrinking Sphere Kinetics

A common error in naive dissolution models is treating surface area $A$ as a static constant. As mass dissolves, the particle shrinks. Assuming $N$ identical spherical particles of density $\rho$, the single particle mass is $m_p = \frac{4}{3}\pi r^3 \rho$ and surface area is $a_p = 4\pi r^2$. Taking the time derivative:

Particle Radius Shrinkage ODE: $$\frac{dr}{dt} = - \frac{D}{\rho \cdot h} \cdot \left(C_s - C(t)\right) \quad (r > 0)$$
Bulk Concentration ODE: $$\frac{dC}{dt} = \frac{N \cdot 4\pi r(t)^2 \cdot D}{h \cdot V} \cdot \left(C_s - C(t)\right)$$

When $C \ll C_s$ (steady sink condition), integrating the radius equation directly yields the classic Hixson–Crowell Cube-Root Law: $M_0^{1/3} - M(t)^{1/3} = \kappa \cdot t$.

Comments